Weight loss improved glucose control but briefly intensified hypothalamic inflammation in mid-aged mice, study finds

Imethibitishwa ukweli

Weight loss reversed obesity-related glucose problems in both young and mid-aged mice, but researchers at Ben-Gurion University of the Negev report that, in mid-aged animals, early weight loss coincided with a temporary rise in inflammation-related changes in the hypothalamus, a brain region involved in appetite and energy regulation.

Obesity is widely recognized as a major health problem, and weight loss is often recommended to reduce metabolic risks. But new research in mice suggests the brain may respond differently to weight loss in midlife than it does earlier in adulthood.

Researchers at Ben-Gurion University of the Negev examined young adult and mid-aged mice that became obese on a high-fat diet and were then switched back to standard chow to induce weight loss. In both age groups, the dietary switch rapidly normalized measures of blood-sugar control and glucose tolerance, indicating that key metabolic benefits of weight loss were seen regardless of age.

In mid-aged mice, however, the team found that early weight loss was accompanied by increased signs of inflammation in the hypothalamus, including changes in microglia—immune cells in the brain—detected through molecular analyses and microscopic imaging. The ScienceDaily summary of the work reported that this inflammatory response lasted several weeks before gradually declining.

The authors emphasize that the findings come from an animal model and do not establish that weight loss causes cognitive decline in people. Still, the researchers note that dysregulated or persistent neuroinflammation has been associated in other research with memory problems and neurodegenerative diseases, and they argue that the brain’s response to weight loss in midlife warrants closer study.

"Our findings show that losing weight in midlife is not a simple copy-and-paste of what works in young adulthood," said Alon Zemer, an M.D.-Ph.D. candidate and first author, in materials released by the university. "Weight loss remains essential for restoring metabolic health in obesity, but we need to understand the impact of weight loss on the mid-age brain and ensure brain health is not compromised."

Dr. Alexandra Tsitrina, also quoted in the release, said the study paired molecular profiling with structural imaging approaches to detect subtle changes during weight loss.

The study, titled "Weight loss aggravates obesity-induced hypothalamic inflammation in mid-aged mice," was published in the journal GeroScience. The university said the work was supported by an internal grant at Ben-Gurion University of the Negev, as well as grants from the U.S.-Israel Binational Science Foundation and the Israel Science Foundation.

Researchers said additional studies are needed to clarify why hypothalamic inflammatory changes appear to intensify during early weight loss in mid-aged mice and whether different weight-loss strategies could preserve metabolic benefits while limiting potential brain stress.

Makala yanayohusiana

Realistic illustration of obese mouse with FGF19 hormone pathway from gut to brain activating fat-burning brown adipose tissue for thermogenesis and obesity treatment research.
Picha iliyoundwa na AI

FGF19 hormone activates brain pathway to boost fat burning in obese mice

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

A study in obese mice has found that the gut-derived hormone FGF19 can signal the brain to increase energy expenditure and activate fat-burning cells. Acting through the hypothalamus and the sympathetic nervous system, this mechanism enhances thermogenesis and cold tolerance and may help guide new treatments for obesity and diabetes.

A new study from University of Utah Health reveals that while the ketogenic diet prevents weight gain in mice, it leads to serious metabolic problems like fatty liver disease and impaired blood sugar control over time. Male mice experienced the most severe effects, including liver damage. The findings, published in Science Advances, question the diet's long-term safety for metabolic health.

Imeripotiwa na AI Imethibitishwa ukweli

Scientists are probing brain circuits affected by GLP-1 medicines such as Ozempic, Wegovy, Mounjaro, and Zepbound to preserve weight-loss benefits while curbing nausea. The findings, presented at Neuroscience 2025, outline strategies that could refine treatments for obesity and type 2 diabetes.

A large genetic study has found that sharp rises in blood sugar after meals could significantly heighten the risk of Alzheimer’s disease. Researchers from the University of Liverpool analyzed data from over 350,000 UK Biobank participants, revealing a 69% increased risk linked to postprandial hyperglycemia. The effect appears independent of visible brain damage, pointing to subtler biological mechanisms.

Imeripotiwa na AI Imethibitishwa ukweli

A new imaging study suggests that higher muscle mass and a lower ratio of visceral fat to muscle are associated with a younger biological brain age. Presented at the Radiological Society of North America’s annual meeting, the research highlights how body composition may influence brain health and future risk of diseases such as Alzheimer’s.

A new genetic study indicates that obesity and high blood pressure directly contribute to dementia, beyond merely raising its risk. Researchers from Denmark and the U.K. used advanced methods to establish this causal link, emphasizing prevention through weight and blood pressure management. The findings suggest early interventions could avert vascular-related dementia.

Imeripotiwa na AI Imethibitishwa ukweli

Researchers at Washington University School of Medicine in St. Louis report that amyloid pathology in mouse models of Alzheimer’s disease disrupts circadian rhythms in microglia and astrocytes, altering the timing of hundreds of genes. Published October 23, 2025, in Nature Neuroscience, the study suggests that stabilizing these cell-specific rhythms could be explored as a treatment strategy.

Jumanne, 27. Mwezi wa kwanza 2026, 23:16:35

Study links sugar metabolism shifts to a temporary survival program in injured neurons

Jumatatu, 26. Mwezi wa kwanza 2026, 22:26:57

Study reveals Alzheimer's synapse loss via shared molecular pathway

Jumamosi, 24. Mwezi wa kwanza 2026, 14:11:57

Study links GDF3 signaling in aging macrophages to heightened inflammation and worse outcomes in infection models

Jumatatu, 19. Mwezi wa kwanza 2026, 11:12:00

Breast cancer disrupts brain rhythms early in mice

Alhamisi, 15. Mwezi wa kwanza 2026, 04:46:47

New studies highlight body fat's roles in immunity and blood pressure

Ijumaa, 26. Mwezi wa kumi na mbili 2025, 03:00:39

Removing aging brain cells eases epilepsy in mice

Jumatano, 24. Mwezi wa kumi na mbili 2025, 13:01:14

Scientists reverse advanced Alzheimer's in mice by restoring brain energy

Jumatatu, 15. Mwezi wa kumi na mbili 2025, 05:00:02

Healthy habits may make the brain appear up to eight years younger, study finds

Jumapili, 14. Mwezi wa kumi na mbili 2025, 15:48:47

Harvard-led study maps gut metabolites that may shape obesity and diabetes risk

Jumapili, 30. Mwezi wa kumi na moja 2025, 10:49:22

UC Riverside study links soybean oil-derived oxylipins to obesity in mice

 

 

 

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa